Takahisa Hanada

1.5k total citations
18 papers, 1.2k citations indexed

About

Takahisa Hanada is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Takahisa Hanada has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 11 papers in Psychiatry and Mental health and 6 papers in Molecular Biology. Recurrent topics in Takahisa Hanada's work include Neuroscience and Neuropharmacology Research (13 papers), Epilepsy research and treatment (11 papers) and Ion channel regulation and function (5 papers). Takahisa Hanada is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Epilepsy research and treatment (11 papers) and Ion channel regulation and function (5 papers). Takahisa Hanada collaborates with scholars based in Japan and United States. Takahisa Hanada's co-authors include Michael A. Rogawski, Osamu Takenaka, Makoto Ohgoh, Aichi Ogasawara, N. Kohmura, Yukio Nishizawa, Shinji Hatakeyama, Masataka Ueno, Yutaka Hashizume and Naoki Tokuhara and has published in prestigious journals such as Neurology, Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

Takahisa Hanada

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takahisa Hanada Japan 14 698 555 388 342 136 18 1.2k
Karine Leclercq Belgium 14 660 0.9× 623 1.1× 420 1.1× 255 0.7× 18 0.1× 27 949
Robert L. Gladding United States 20 347 0.5× 166 0.3× 204 0.5× 399 1.2× 64 0.5× 46 1.3k
Stephen L. Yates United States 16 216 0.3× 254 0.5× 216 0.6× 310 0.9× 40 0.3× 30 838
Makoto Ohgoh Japan 11 366 0.5× 233 0.4× 162 0.4× 231 0.7× 20 0.1× 16 668
Kerstin Römermann Germany 21 331 0.5× 378 0.7× 427 1.1× 295 0.9× 19 0.1× 30 1.1k
Wadad Saba France 18 318 0.5× 109 0.2× 75 0.2× 248 0.7× 56 0.4× 45 905
Naoki Tokuhara Japan 9 250 0.4× 219 0.4× 155 0.4× 191 0.6× 59 0.4× 19 520
Kimberly J. Jenko United States 16 299 0.4× 255 0.5× 74 0.2× 431 1.3× 38 0.3× 26 1.4k
Susan A. Borosky United States 12 552 0.8× 125 0.2× 48 0.1× 479 1.4× 95 0.7× 16 988
Lucette Garreau France 16 519 0.7× 77 0.1× 31 0.1× 386 1.1× 65 0.5× 39 1.1k

Countries citing papers authored by Takahisa Hanada

Since Specialization
Citations

This map shows the geographic impact of Takahisa Hanada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahisa Hanada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahisa Hanada more than expected).

Fields of papers citing papers by Takahisa Hanada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahisa Hanada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahisa Hanada. The network helps show where Takahisa Hanada may publish in the future.

Co-authorship network of co-authors of Takahisa Hanada

This figure shows the co-authorship network connecting the top 25 collaborators of Takahisa Hanada. A scholar is included among the top collaborators of Takahisa Hanada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahisa Hanada. Takahisa Hanada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fukushima, Kazuyuki, Hiroyuki Higashiyama, Yuji Kazuta, et al.. (2023). Discovery ofE2730, a novel selective uncompetitiveGAT1inhibitor, as a candidate for anti‐seizure medication. Epilepsia Open. 8(3). 834–845. 5 indexed citations
2.
Hanada, Takahisa. (2020). Ionotropic Glutamate Receptors in Epilepsy: A Review Focusing on AMPA and NMDA Receptors. Biomolecules. 10(3). 464–464. 177 indexed citations
3.
Kaji, Ryuji, Takashi Imai, Yasuo Iwasaki, et al.. (2019). Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study. Journal of Neurology Neurosurgery & Psychiatry. 90(4). 451–457. 60 indexed citations
4.
5.
Watanabe, Haruki, Keyue Liu, Sumie Hiramatsu, et al.. (2017). Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice. Molecular Therapy — Methods & Clinical Development. 6. 31–39. 15 indexed citations
6.
Ido, Katsutoshi, et al.. (2017). The neuroprotective effect of perampanel in lithium-pilocarpine rat seizure model. Epilepsy Research. 137. 152–158. 25 indexed citations
8.
Kobayashi, Kazuko, Takanori Sasaki, Takahisa Hanada, et al.. (2016). The Function of β2-glycoprotein I in Angiogenesis and Its in Vivo Distribution in Tumor Xenografts.. PubMed. 70(1). 13–24. 1 indexed citations
9.
Kobayashi, Toshiki, Yuki Furusawa, Takanori Sasaki, et al.. (2015). Positron Emission Tomography to Elucidate Pharmacokinetic Differences of Regioisomeric Retinoid X Receptor Agonists. ACS Medicinal Chemistry Letters. 6(3). 334–338. 13 indexed citations
10.
11.
Hanada, Takahisa, et al.. (2014). Pharmacodynamic and pharmacokinetic interactions of perampanel and other antiepileptic drugs in a rat amygdala kindling model. Seizure. 23(9). 732–739. 26 indexed citations
12.
Hanada, Takahisa. (2014). The discovery and development of perampanel for the treatment of epilepsy. Expert Opinion on Drug Discovery. 9(4). 449–458. 63 indexed citations
13.
Hanada, Takahisa, Katsutoshi Ido, & Takashi Kosasa. (2014). Effect of perampanel, a novel AMPA antagonist, on benzodiazepine‐resistant status epilepticus in a lithium‐pilocarpine rat model. Pharmacology Research & Perspectives. 2(5). e00063–e00063. 49 indexed citations
14.
Hanada, Takahisa, et al.. (2014). Anti-Seizure Effects of Perampanel in Combination with Other Antiepileptic Drugs (AEDs) in a Rat Amygdala Kindling Model (P3.270). Neurology. 82(10_supplement). 1 indexed citations
15.
Rogawski, Michael A. & Takahisa Hanada. (2013). Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist. Acta Neurologica Scandinavica. 127(197). 19–24. 184 indexed citations
16.
Hibi, Shigeki, Satoshi Nagato, Koichi Ito, et al.. (2012). Discovery of 2-(2-Oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl)benzonitrile (Perampanel): A Novel, Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropanoic Acid (AMPA) Receptor Antagonist. Journal of Medicinal Chemistry. 55(23). 10584–10600. 146 indexed citations
17.
Hanada, Takahisa, Yutaka Hashizume, Naoki Tokuhara, et al.. (2011). Perampanel: A novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia. 52(7). 1331–1340. 318 indexed citations
18.
Kimura, M., Yoshinori Yamanishi, Takahisa Hanada, et al.. (1995). Involvement of P-type calcium channels in high potassium-elicited release of neurotransmitters from rat brain slices. Neuroscience. 66(3). 609–615. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026